Latest market price
473.19
-4.89-1.02%
HCAQT68HCA Healthcare, Inc.·NYSE
473.19-1.02%
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E15.68EPS (ttm)30.18Insider Own—Shs Outstand216.50MPerf Week0.89%
Market Cap102.45BForward P/E15.03EPS next Y31.48Insider Trans0.00%Shs Float144.67MPerf Month11.76%
Enterprise Value153.96BPEG1.50EPS next Q—Short Float3.39%Perf Quarter16.37%
Income6.78BP/S1.30EPS this Y8.31%Short Ratio3.62Perf Half Y9.26%
Sales78.70BP/B—EPS next Y4.99%ROA10.68%Short Interest4.91MPerf YTD1.36%
Book/sh-21.24P/C112.83EPS next 5Y10.45%ROE—52W High556.52 -14.97%Perf Year1.02%
Cash/sh4.19P/FCF17.15EPS past 3/5Y14.01% 21.03%ROIC18.52%52W Low353.99 33.67%Perf 3Y109.97%
Dividend Est.3.12 (0.66%)EV/EBITDA9.68Sales past 3/5Y7.87% 7.97%Gross Margin21.69%Volatility4.71% 3.01%Perf 5Y86.95%
Dividend TTM3.06 (0.65%)EV/Sales1.96EPS Y/Y TTM16.66%Oper. Margin15.34%ATR (14)14.81Perf 10Y476.99%
Dividend Ex-DateDec 15, 2026Quick Ratio0.74Sales Y/Y TTM5.82%Profit Margin8.61%RSI (14)60.69Recom2.41
Dividend Gr. 3/5Y8.74% 46.28%Current Ratio0.82EPS Q/Q3.74%SMA203.25%Beta1.10Target Price463.12
Payout10.05%Debt/Eq—Sales Q/Q3.59%SMA508.18%Rel Volume0.85Prev Close478.08
Employees320,000LT Debt/Eq—EarningsJan 26SMA2006.48%Avg Volume1.32MPrice473.19
IPO DateMar 10, 2011Option/ShortYes / YesEPS/Sales Surpr.8.52% 2.70%Net Debt/EBITDA3.24Volume1,116,853Change-1.02%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-29-26ReiteratedBarclaysEqual Weight$387 → $401
Oct-28-26ReiteratedMizuho SecuritiesOutperform$475 → $495
Oct-28-26ReiteratedKeybancOverweight$435 → $490
Oct-07-26ReiteratedRBC CapitalOutperform$435 → $496
Sep-22-26InitiatedBMO CapitalOutperform$495
Jul-28-26ReiteratedGoldman SachsBuy$520 → $485
Jul-27-26ReiteratedDeutsche BankBuy$540 → $476
Jul-27-26ReiteratedRobert W. Baird$396 → $393
Jul-27-26ReiteratedOppenheimerOutperform$520 → $485
Jul-27-26ReiteratedMorgan StanleyUnderweight$425 → $380
Latest News· Times ET
Oct-29-26
Oct-28-26
Oct-27-26
Oct-26-26
Company

HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue78,70175,60070,60364,968—————
Cost of Goods Sold Incl. D&A61,63144,22641,92539,389—————
Gross Profit17,07031,37428,67825,579—————
Selling, General and Administrative Excl. Other24,4347,99731,17029,487—————
Research and Development
0000—————
Other Operating Expense-19,43611,412-13,039-13,535—————
Operating Income12,07211,96510,5479,627—————
Interest Expense2,3622,2482,0611,938—————
Unusual Expense
—————————
Non-Operating Income (Expense)1131153717—————
Net Income Before Taxes9,8239,8328,5237,706—————
Income Taxes2,0242,0501,8661,615—————
Consolidated Net Income6,7766,7845,7605,242—————
Net Income From Continuing Operations7,7997,7826,6576,091—————
Net Income6,7766,7845,7605,242—————
EPS (Recurring)8.2428.6222.2719.24—————
EPS (Basic, Before Extraordinaries)8.2428.6222.2719.24—————
EPS (Diluted)30.1828.3822.0018.96—————
EBITDA15,89815,60313,89612,721—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio15.6816.4513.6414.28—————
Price To Sales Ratio1.331.431.101.13—————
Gross Margin21.6941.5040.6239.37—————
Operating Margin15.3415.8314.9414.82—————
Net Margin8.618.978.168.07—————
Shares Outstanding222231259272—————
Market Capitalization105,048107,84577,73973,625—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$572.70$512.96$453.23$393.49$333.75● Close Price0.00M7.32M14.64M21.96M29.28MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
McAlevey Michael REVP & Chief Legal & Admin Off.Feb 18 '26Sale533.371,694903,5378,853Feb 18
McAlevey Michael REVP & Chief Legal & Admin Off.Feb 13 '26Option Exercise236.615,0001,183,05013,853Feb 18
Berres JenniferSVP & Chief Human Res. OfficerFeb 11 '26Sale514.588,0204,126,95011,993Feb 12
Wyatt Christopher F.SVP & ControllerFeb 11 '26Sale505.004,0002,020,00044,379Feb 12
Wyatt Christopher F.SVP & ControllerFeb 05 '26Option Exercise139.0610,6701,483,77051,737Feb 09
Foster Jon MEVP and COOFeb 05 '26Option Exercise139.0629,3304,078,63029,330Feb 09
HAZEN SAMUEL NCEOFeb 03 '26Sale501.0442,87721,483,27532,276Feb 05
Cuffe Michael S.EVP and Chief Clinical OfficerFeb 03 '26Sale498.091,500747,13530,003Feb 05
HAZEN SAMUEL NCEOJan 30 '26Option Exercise81.9684,3606,914,146116,636Feb 02
McAlevey Michael REVP & Chief Legal & Admin Off.Nov 05 '25Sale473.793,8921,843,9913,487Nov 05
McAlevey Michael REVP & Chief Legal & Admin Off.Nov 03 '25Option Exercise236.6113,1703,116,15416,657Nov 05
HAZEN SAMUEL NCEOOct 31 '25Option Exercise69.5858,0504,039,11975,279Nov 04
Cuffe Michael S.EVP and Chief Clinical OfficerSep 08 '25Sale418.843,8361,606,67031,503Sep 08
Cuffe Michael S.EVP and Chief Clinical OfficerSep 04 '25Option Exercise173.1210,9201,890,47042,423Sep 08
Foster Jon MEVP and COOMay 13 '25Sale369.3215,6985,797,66112,646May 15
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.